15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain

Human Molecular Genetics

Volumn 20, Issue 22, 2011, Pages 4311-4323

  Yasui, Dag H ^a   Scoles, Haley A ^a   Horike, Shin Ichi ^b   Meguro Horike, Makiko ^b   Dunaway, Keith W ^a   Schroeder, Diane I ^a   Lasalle, Janine M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR NICOTINIC ALPHA 7; METHYL CPG BINDING PROTEIN 2; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTISM; BINDING SITE; CHILD; CHROMATIN CONDENSATION; CHROMATIN STRUCTURE; CHROMOSOME 15Q; CHROMOSOME ANALYSIS; CHROMOSOME CAPTURE CONFORMATION ON CHIP ANALYSIS; CHROMOSOME MAP; CLINICAL ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; FRONTAL CORTEX; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENETIC TRANSCRIPTION; GENOME IMPRINTING; HUMAN; HUMAN CELL; INFANT; MOLECULAR INTERACTION; NEUROBLASTOMA CELL; PRADER WILLI SYNDROME IMPRINTING CENTER; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETT SYNDROME; SCHOOL CHILD; TRANSCRIPTION REGULATION;

AUTISTIC DISORDER; BINDING SITES; BRAIN; CELL LINE, TUMOR; CHROMATIN; CHROMOSOMES, HUMAN, PAIR 15; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; METHYL-CPG-BINDING PROTEIN 2; PRADER-WILLI SYNDROME; RECEPTORS, NICOTINIC; RETT SYNDROME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80054957569     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr357     Document Type: Article

References (66)

1. Ohta, T., Gray, T.A., Rogan, P.K., Buiting, K., Gabriel, J.M., Saitoh, S., Muralidhar, B., Bilienska, B., Krajewska-Walasek, M., Driscoll, D.J. et al. (1999) Imprinting-mutation mechanisms in Prader-Willi syndrome. Am. J. Hum. Genet., 64, 397-413.
2. Holm, V.A., Cassidy, S.B., Butler, M.G., Hanchett, J.M., Greenswag, L.R., Whitman, B.Y. and Greenberg, F. (1993) Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics, 91, 398-402.
3. Buiting, K., Lich, C., Cottrell, S., Barnicoat, A. and Horsthemke, B. (1999) A 5-kb imprinting center deletion in a family with Angelman syndrome reduces the shortest region of deletion overlap to 880 bp. Hum. Genet., 105, 665-666.
4. Horsthemke, B. and Wagstaff, J. (2008) Mechanisms of imprinting of the Prader-Willi/Angelman region. Am. J. Med. Genet. A, 146A, 2041-2052.
5. Peng, X., Katz, M., Gerzanich, V., Anand, R. and Lindstrom, J. (1994) Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol. Pharmacol., 45, 546-554.
6. Kishino, T., Lalande, M. and Wagstaff, J. (1997) UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet., 15, 70-73.
7. Buxbaum, J.D., Silverman, J.M., Smith, C.J., Greenberg, D.A., Kilifarski, M., Reichert, J., Cook, E.H. Jr., Fang, Y., Song, C.Y. and Vitale, R. (2002) Association between a GABRB3 polymorphism and autism. Mol. Psychiatry, 7, 311-316.
8. Schroer, R.J., Phelan, M.C., Michaelis, R.C., Crawford, E.C., Skinner, S.A., Cuccaro, M., Simensen, R.J., Bishop, J., Skinner, C., Fender, D. et al. (1998) Autism and maternally derived aberrations of chromosome 15q. Am. J. Med. Genet., 76, 327-336.
9. Runte, M., Varon, R., Horn, D., Horsthemke, B. and Buiting, K. (2005) Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader-Willi syndrome. Hum. Genet., 116, 228-230.
10. Leung, K.N., Vallero, R.O., DuBose, A.J., Resnick, J.L. and LaSalle, J.M. (2009) Imprinting regulates mammalian snoRNA-encoding chromatin decondensation and neuronal nucleolar size. Hum. Mol. Genet., 18, 4227-4238.
11. Yasui, D.H., Peddada, S., Bieda, M.C., Vallero, R.O., Hogart, A., Nagarajan, R.P., Thatcher, K.N., Farnham, P.J. and Lasalle, J.M. (2007) Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl Acad. Sci. USA, 104, 19416-19421.
12. Peddada, S., Yasui, D.H. and LaSalle, J.M. (2006) Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum. Mol. Genet., 15, 2003-2014.
13. Yang, T., Adamson, T.E., Resnick, J.L., Leff, S., Wevrick, R., Francke, U., Jenkins, N.A., Copeland, N.G. and Brannan, C.I. (1998) A mouse model for Prader-Willi syndrome imprinting-centre mutations. Nat. Genet., 19, 25-31.
14. Chini, B., Raimond, E., Elgoyhen, A.B., Moralli, D., Balzaretti, M. and Heinemann, S. (1994) Molecular cloning and chromosomal localization of the human alpha 7-nicotinic receptor subunit gene (CHRNA7). Genomics, 19, 379-381.
15. Gault, J., Robinson, M., Berger, R., Drebing, C., Logel, J., Hopkins, J., Moore, T., Jacobs, S., Meriwether, J., Choi, M.J. et al. (1998) Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics, 52, 173-185.
16. Miller, D.T., Shen, Y., Weiss, L.A., Korn, J., Anselm, I., Bridgemohan, C., Cox, G.F., Dickinson, H., Gentile, J., Harris, D.J. et al. (2009) Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J. Med. Genet., 46, 242-248.
17. Ben-Shachar, S., Lanpher, B., German, J.R., Qasaymeh, M., Potocki, L., Nagamani, S.C., Franco, L.M., Malphrus, A., Bottenfield, G.W., Spence, J.E. et al. (2009) Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J. Med. Genet., 46, 382-388.
18. Shinawi, M., Schaaf, C.P., Bhatt, S.S., Xia, Z., Patel, A., Cheung, S.W., Lanpher, B., Nagl, S., Herding, H.S., Nevinny-Stickel, C. et al. (2009) A small recurrent deletion within 15q13.3 is associated with a range of neurodevelopmental phenotypes. Nat. Genet., 41, 1269-1271.
19. Sharp, A.J., Mefford, H.C., Li, K., Baker, C., Skinner, C., Stevenson, R.E., Schroer, R.J., Novara, F., De Gregori, M., Ciccone, R. et al. (2008) A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat. Genet., 40, 322-328.
20. Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M. et al. (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl Acad. Sci. USA, 94, 587-592.
21. Helbig, I., Mefford, H.C., Sharp, A.J., Guipponi, M., Fichera, M., Franke, A., Muhle, H., de Kovel, C., Baker, C., von Spiczak, S. et al. (2009) 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat. Genet., 41, 160-162.
22. Stefansson, H., Rujescu, D., Cichon, S., Pietilainen, O.P., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., Buizer-Voskamp, J.E. et al. (2008) Large recurrent microdeletions associated with schizophrenia. Nature, 455, 232-236.
23. Orr-Urtreger, A., Goldner, F.M., Saeki, M., Lorenzo, I., Goldberg, L., De Biasi, M., Dani, J.A., Patrick, J.W. and Beaudet, A.L. (1997) Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci., 17, 9165-9171.
24. Levin, E.D., Petro, A., Rezvani, A.H., Pollard, N., Christopher, N.C., Strauss, M., Avery, J., Nicholson, J. and Rose, J.E. (2009) Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. Behav. Brain Res., 196, 207-213.
25. Fernandes, C., Hoyle, E., Dempster, E., Schalkwyk, L.C. and Collier, D.A. (2006) Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory. Genes Brain Behav., 5, 433-440.
26. Tsankova, N., Renthal, W., Kumar, A. and Nestler, E.J. (2007) Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci., 8, 355-367.
27. Samaco, R.C., Hogart, A. and LaSalle, J.M. (2005) Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet., 14, 483-492.
28. Lasalle, J.M. and Yasui, D.H. (2009) Evolving role of MeCP2 in Rett syndrome and autism. Epigenomics, 1, 119-130.
29. Neul, J.L. and Zoghbi, H.Y. (2004) Rett syndrome: a prototypical neurodevelopmental disorder. Neuroscientist, 10, 118-128.
30. Fatemi, M. and Wade, P.A. (2006) MBD family proteins: reading the epigenetic code. J. Cell. Sci., 119, 3033-3037.
31. Lewis, J.D., Meehan, R.R., Henzel, W.J., Maurer-Fogy, I., Jeppesen, P., Klein, F. and Bird, A. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell, 69, 905-914.
32. Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, S.U., Landsberger, N., Strouboulis, J. and Wolffe, A.P. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 19, 187-191.
33. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N. and Bird, A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386-389.
34. Horike, S., Cai, S., Miyano, M., Cheng, J.F. and Kohwi-Shigematsu, T. (2005) Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet., 37, 31-40.
35. Nikitina, T., Ghosh, R.P., Horowitz-Scherer, R.A., Hansen, J.C., Grigoryev, S.A. and Woodcock, C.L. (2007) MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J. Biol. Chem., 282, 28237-28245.
36. Nikitina, T., Shi, X., Ghosh, R.P., Horowitz-Scherer, R.A., Hansen, J.C. and Woodcock, C.L. (2007) Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Mol. Cell. Biol., 27, 864-877.
37. Ghosh, R.P., Nikitina, T., Horowitz-Scherer, R.A., Gierasch, L.M., Uversky, V.N., Hite, K., Hansen, J.C. and Woodcock, C.L. (2010) Unique physical properties and interactions of the domains of methylated DNA binding protein 2. Biochemistry, 49, 4395-4410.
38. Hogart, A., Nagarajan, R.P., Patzel, K.A., Yasui, D.H. and Lasalle, J.M. (2007) 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Hum. Mol. Genet., 16, 691-703.
39. Simonis, M., Klous, P., Splinter, E., Moshkin, Y., Willemsen, R., de Wit, E., van Steensel, B. and de Laat, W. (2006) Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C). Nat. Genet., 38, 1348-1354.
40. Simonis, M., Kooren, J. and de Laat, W. (2007) An evaluation of 3C-based methods to capture DNA interactions. Nat. Methods, 4, 895-901.
41. Jung, B.P., Jugloff, D.G., Zhang, G., Logan, R., Brown, S. and Eubanks, J.H. (2003) The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J. Neurobiol., 55, 86-96.
42. Pahlman, S., Mamaeva, S., Meyerson, G., Mattsson, M.E., Bjelfman, C., Ortoft, E. and Hammerling, U. (1990) Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol. Scand. Suppl., 592, 25-37.
43. Murrell, A., Heeson, S. and Reik, W. (2004) Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops. Nat. Genet., 36, 889-893.
44. Ohlsson, R. and Gondor, A. (2007) The 4C technique: the 'Rosetta stone' for genome biology in 3D? Curr. Opin. Cell Biol., 19, 321-325.
45. Bieda, M., Xu, X., Singer, M.A., Green, R. and Farnham, P.J. (2006) Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. Genome Res., 16, 595-605.
46. Sahoo, T., del Gaudio, D., German, J.R., Shinawi, M., Peters, S.U., Person, R.E., Garnica, A., Cheung, S.W. and Beaudet, A.L. (2008) Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat. Genet., 40, 719-721.
47. Abrahams, B.S. and Geschwind, D.H. (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet., 9, 341-355.
48. Mexal, S., Berger, R., Logel, J., Ross, R.G., Freedman, R. and Leonard, S. (2010) Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers. J. Mol. Neurosci., 40, 185-195.
49. Guan, Z.Z., Zhang, X., Blennow, K. and Nordberg, A. (1999) Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport, 10, 1779-1782.
50. Nagarajan, R.P., Hogart, A.R., Gwye, Y., Martin, M.R. and LaSalle, J.M. (2006) Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics, 1, e1-e11.
51. Nicholls, R.D. and Knepper, J.L. (2001) Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet., 2, 153-175.
52. Girirajan, S. and Eichler, E.E. (2010) Phenotypic variability and genetic susceptibility to genomic disorders. Hum. Mol. Genet., 19, 176-187.
53. Bond, A.M., Vangompel, M.J., Sametsky, E.A., Clark, M.F., Savage, J.C., Disterhoft, J.F. and Kohtz, J.D. (2009) Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat. Neurosci., 12, 1020-1027.
54. Stefan, M., Portis, T., Longnecker, R. and Nicholls, R.D. (2005) A nonimprinted Prader-Willi syndrome (PWS)-region gene regulates a different chromosomal domain in trans but the imprinted pws loci do not alter genome-wide mRNA levels. Genomics, 85, 630-640.
55. Skene, P.J., Illingworth, R.S., Webb, S., Kerr, A.R., James, K.D., Turner, D.J., Andrews, R. and Bird, A.P. (2010) Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol. Cell, 37, 457-468.
56. Klin, A., Lang, J., Cicchetti, D.V. and Volkmar, F.R. (2000) Brief report: interrater reliability of clinical diagnosis and DSM-IV criteria for autistic disorder: results of the DSM-IV autism field trial. J. Autism Dev. Disord., 30, 163-167.
57. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185-188.
58. Silk, T.J., Rinehart, N., Bradshaw, J.L., Tonge, B., Egan, G., O'Boyle, M.W. and Cunnington, R. (2006) Visuospatial processing and the function of prefrontal-parietal networks in autism spectrum disorders: a functional MRI study. Am. J. Psychiatry, 163, 1440-1443.
59. Gemelli, T., Berton, O., Nelson, E.D., Perrotti, L.I., Jaenisch, R. and Monteggia, L.M. (2006) Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biol. Psychiatry, 59, 468-476.
60. Adachi, M., Keefer, E.W. and Jones, F.S. (2005) A segment of the Mecp2 promoter is sufficient to drive expression in neurons. Hum. Mol. Genet., 14, 3709-3722.
61. Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T., Qin, J. and Zoghbi, H.Y. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science, 320, 1224-1229.
62. Agulhon, C., Abitbol, M., Bertrand, D. and Malafosse, A. (1999) Localization of mRNA for CHRNA7 in human fetal brain. Neuroreport, 10, 2223-2227.
63. Samaco, R.C., Nagarajan, R.P., Braunschweig, D. and LaSalle, J.M. (2004) Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum. Mol. Genet., 13, 629-639.
64. Chang, Q., Khare, G., Dani, V., Nelson, S. and Jaenisch, R. (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron, 49, 341-348.
65. Jiang, Y., Langley, B., Lubin, F.D., Renthal, W., Wood, M.A., Yasui, D.H., Kumar, A., Nestler, E.J., Akbarian, S. and Beckel-Mitchener, A.C. (2008) Epigenetics in the nervous system. J. Neurosci., 28, 11753-11759.
66. Tregellas, J.R., Tanabe, J., Rojas, D.C., Shatti, S., Olincy, A., Johnson, L., Martin, L.F., Soti, F., Kem, W.R., Leonard, S. et al. (2010) Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia. Biol. Psychiatry, 69, 7-11.